Browse Category

Company Updates News 31 October 2025 - 11 November 2025

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) News Today—November 11, 2025: UBS Sees 2026 Upside, Redburn Cuts PT to $36, Bernstein Stays Market Perform After Cost Cuts

Published: November 11, 2025 Moderna, Inc. (NASDAQ: MRNA) drew multiple analyst headlines today as Wall Street recalibrated views in the wake of last week’s earnings and ongoing cost‑cutting. UBS highlighted potential 2026 upside on pipeline and expense discipline; Redburn Atlantic
Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

What changed today (Nov. 11, 2025) The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after
Block, Inc. (XYZ) news today: Shares slide post‑earnings as Square profitability lags; Cash App strength, new product “Releases,” and Investor Day in focus (Nov 9, 2025)

Block, Inc. (XYZ) news today: Shares slide post‑earnings as Square profitability lags; Cash App strength, new product “Releases,” and Investor Day in focus (Nov 9, 2025)

Block, Inc. (XYZ) fell sharply after Q3 2025 results as Square’s profit growth trailed payment volumes, even as Cash App surged. Here are today’s headlines, the key numbers, and what to watch this week—including Cash App Releases on Nov. 13
Nebius (NBIS) Stock Rockets 350% on AI Boom – Bubble or Breakout? Experts Weigh In

Nebius (NBIS) Stock Today — 7 November 2025: Shares Close at $111.28 as UK NVIDIA Blackwell Rollout and New “Token Factory” Drive Momentum

Ticker: NBIS (Nasdaq)Sector: AI infrastructure / cloud compute Nebius stock price today (7 Nov 2025) Nebius Group N.V. (NBIS) closed at $111.28, up $1.84 (+1.68%) from the prior close. The session ranged $101.26–$111.30 after an $104.50 open, with ~17.6 million
SoFi Technologies (SOFI) Today — Nov. 7, 2025: Shares Ease After Big Run as Fresh Analyst Takes, New Forecasts and “Risk Reduction” Move Make Headlines

SoFi Technologies (SOFI) Today — Nov. 7, 2025: Shares Ease After Big Run as Fresh Analyst Takes, New Forecasts and “Risk Reduction” Move Make Headlines

SoFi Technologies, Inc. (NASDAQ: SOFI) is trading lower in Friday action after a powerful multi‑week rally, with new same‑day coverage highlighting a short‑term pullback, mixed Wall Street views, and commentary that the company is “reducing risk” in its model—an investor‑friendly
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged
Datadog (DDOG) Jumps After Q3 2025 Beat: $886M Revenue, $0.55 EPS; Full‑Year Outlook Raised

Datadog (DDOG) Jumps After Q3 2025 Beat: $886M Revenue, $0.55 EPS; Full‑Year Outlook Raised

Cloud observability and security provider Datadog (NASDAQ: DDOG) posted a stronger‑than‑expected third quarter and lifted its full‑year guidance, citing continued momentum with large customers and rapid product innovation in AI observability and security. The company reported revenue of $886 million
Go toTop